Načítá se...
Manipulating megakaryocytes to manufacture platelets ex vivo
Historically, platelet transfusion has proven a reliable way to treat patients suffering from thrombocytopenia or similar ailments. An undersupply of donors, however, has demanded alternative platelet sources. Scientists have therefore sought to recapitulate the biological events that convert hemato...
Uloženo v:
| Vydáno v: | J Thromb Haemost |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Publishing Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501322/ https://ncbi.nlm.nih.gov/pubmed/26149050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.12946 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|